# Safety and PK of MMV371 LAI in Healthy Adults and Adolescents in Rwanda

> **NCT07548021** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Medicines for Malaria Venture** · enrollment: 80 (estimated)

## Conditions studied

- Malaria (Plasmodium Falciparum)
- Malaria Falciparum
- Malaria Infection
- Malaria Prophylaxis
- Malaria Prevention
- Malaria
- Malaria Parasitaemia

## Interventions

- **DRUG:** MMV371
- **DRUG:** Placebo for MMV371
- **DRUG:** MMV371
- **DRUG:** MMV371

## Key facts

- **NCT ID:** NCT07548021
- **Lead sponsor:** Medicines for Malaria Venture
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2028-03
- **Final completion:** 2028-03
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07548021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07548021, "Safety and PK of MMV371 LAI in Healthy Adults and Adolescents in Rwanda". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07548021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*